Clinical trial network for the promotion of clinical research for rare diseases in Japan: muscular dystrophy clinical trial network

BACKGROUND: Duchenne muscular dystrophy (DMD) is the most commonly inherited neuromuscular disease. Therapeutic agents for the treatment of rare disease, namely “orphan drugs”, have recently drawn the attention of researchers and pharmaceutical companies. To ensure the successful conduction of clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimizu, Reiko, Ogata, Katsuhisa, Tamaura, Akemi, Kimura, En, Ohata, Maki, Takeshita, Eri, Nakamura, Harumasa, Takeda, Shin’ichi, Komaki, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Technical Advance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939632/
https://www.ncbi.nlm.nih.gov/pubmed/27401940
http://dx.doi.org/10.1186/s12913-016-1477-4

Ejemplares similares

Ejemplares similares